Cargando…
OR32-06 Opportunistic Assessment of Pituitary Gland with Routine MRI and PET/CT Can Guide in Earlier and Increased Identification of Hypophysitis in Patients Treated with Combination Checkpoint Inhibitors
Background: Hypophysitis is one of the commonly reported adverse events related to immune checkpoint inhibitors (ICI), and the incidence is expected to rise with increased use of combined programmed cell death protein 1 (PD1) and cytotoxic T lymphocyte associated protein 4 (CTLA4) blockade. The clin...
Autores principales: | Galligan, Anna, Iravani, Amir, Lasocki, Arian, Wallace, Roslyn, Weppler, Alison, Au-Yeung, George, Sachithanandan, Nirupa, Chiang, Cherie Ying, Wentworth, John, Colman, Peter Grahame, Kay, Thomas William, Krishnamurthy, Balasubramanian, Sandhu, Shahneen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208878/ http://dx.doi.org/10.1210/jendso/bvaa046.1494 |
Ejemplares similares
-
SUN-127 Diagnostic Challenges Associated with the Rising Incidence of Endocrine Toxicity in the Era of Combination Immunotherapy
por: Galligan, Anna, et al.
Publicado: (2020) -
Idiopathic Hypophysitis
por: Amjed, Hafsa, et al.
Publicado: (2021) -
SUN-416 Ipilimumab Associated Hypophysitis and Thyroiditis
por: Kazi, Fatima, et al.
Publicado: (2019) -
Rituximab as an Alternative Treatment for Refractory Granulomatous Hypophysitis
por: Nokhbehzaeim, Mahrokh, et al.
Publicado: (2021) -
FRI342 Hypophysitis Mimicking As Pituitary Adenoma
por: Chao, Alex, et al.
Publicado: (2023)